Stockscreener 앱 받기
20.76
3.71%
-0.80
시간 외 거래:
20.76
전일 마감가:
$21.56
열려 있는:
$21.68
하루 거래량:
398.56K
Relative Volume:
0.52
시가총액:
$1.29B
수익:
$10.00M
순이익/손실:
$-377.74M
주가수익비율:
-2.4587
EPS:
-8.4436
순현금흐름:
$-172.35M
1주 성능:
+15.27%
1개월 성능:
-3.26%
6개월 성능:
-32.00%
1년 성능:
+84.70%
1일 변동 폭
$20.27
$22.15
1주일 범위
$17.39
$22.15
52주 변동 폭
$8.51
$44.60
Zenas Biopharma Inc Stock (ZBIO) Company Profile
명칭
Zenas Biopharma Inc
전화
857-271-2954
주소
852 WINTER STREET, SUITE 250, WALTHAM
Compare ZBIO vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZBIO
Zenas Biopharma Inc
|
20.76 | 1.34B | 10.00M | -377.74M | -172.35M | -8.4436 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Zenas Biopharma Inc Stock (ZBIO) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-20 | 개시 | Wedbush | Outperform |
| 2025-02-04 | 개시 | Wolfe Research | Outperform |
| 2024-12-16 | 개시 | H.C. Wainwright | Buy |
| 2024-11-05 | 개시 | Rodman & Renshaw | Buy |
| 2024-10-08 | 개시 | Citigroup | Buy |
| 2024-10-08 | 개시 | Guggenheim | Buy |
| 2024-10-08 | 개시 | Jefferies | Buy |
| 2024-10-08 | 개시 | Morgan Stanley | Overweight |
모두보기
Zenas Biopharma Inc 주식(ZBIO)의 최신 뉴스
Zenas BioPharma (ZBIO) CEO and entities report 3,220,880 shares owned - Stock Titan
Zenas BioPharma rises as CEO continues insider purchases - MSN
A Look At Zenas BioPharma (ZBIO) Valuation After Obexelimab Trial Success And US$300 Million Fundraising - Sahm
ZBIO Stock Price, Quote & Chart | ZENAS BIOPHARMA INC (NASDAQ:ZBIO) - ChartMill
Zenas BioPharma (ZBIO) Price Target Increased by 21.59% to 40.22 - MSN
Zenas: 'Strong Buy' On Obexelimab Enhancement And Expected SLE Data Q4 2026 (NASDAQ:ZBIO) - Seeking Alpha
Zenas BioPharma (NASDAQ:ZBIO) Shares Gap Up on Insider Buying Activity - MarketBeat
Zenas BioPharma rises on CEO insider purchase (ZBIO:NASDAQ) - Seeking Alpha
Zenas BioPharma CEO Makes Bold Move With Major Personal Stock Buy - TipRanks
Zenas BioPharma CEO Moulder buys $1.07m in ZBIO shares By Investing.com - Investing.com Canada
Leon Moulder Jr Purchases 25,000 Shares of Zenas BioPharma (NASDAQ:ZBIO) Stock - MarketBeat
Zenas BioPharma CEO Moulder buys $1.07m in ZBIO shares - Investing.com UK
Zenas BioPharma (ZBIO) CEO-linked entities purchase 60,000 shares in open market - Stock Titan
Zenas BioPharma announces concurrent public offerings of convertible senior notes and common stock - MSN
Here’s Why Zenas BioPharma (ZBIO) Traded Lower in Q1 - Insider Monkey
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Given Average Rating of "Hold" by Analysts - MarketBeat
Is Zenas BioPharma (ZBIO) stock priced efficiently (Weakens) 2026-04-20Community Pattern Alerts - Cổng thông tin điện tử tỉnh Lào Cai
Zenas Biopharma announces inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Zenas Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Zenas BioPharma, Inc. Investigated by the Portnoy Law Firm - GlobeNewswire
Zenas BioPharma, Inc. (ZBIO) Stock Analysis: Exploring a 93% Potential Upside Amidst Analyst Enthusiasm - DirectorsTalk Interviews
Zenas BioPharma, Inc. (NASDAQ:ZBIO) Short Interest Up 21.4% in March - MarketBeat
Zenas BioPharma (ZBIO) Stock Volume Deceleration (On the Radar) 2026-04-15Crowd Entry Signals - Cổng thông tin điện tử Tỉnh Sơn La
Zenas BioPharma (NASDAQ:ZBIO) Issues Quarterly Earnings Results - MarketBeat
ZBIO Options Volatility — NASDAQ:ZBIO - TradingView
ZBIO Options Chain — NASDAQ:ZBIO - TradingView
Breakout Zone: Will Zenas BioPharma Inc outperform during market ralliesWeekly Investment Recap & Consistent Growth Stock Picks - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Zenas BioPharma, Inc. (ZBIO) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Zenas BioPharma, Inc. (ZBIO) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Big Picture: Is Zenas BioPharma Inc attractive at current valuationTake Profit & Safe Capital Growth Stock Tips - baoquankhu1.vn
Returns Recap: Can Zenas BioPharma Inc be the next market leader2026 Macro Impact & Real-Time Chart Breakout Alerts - baoquankhu1.vn
Trend Review: What is the target price for Zenas BioPharma Inc stock2026 Fed Impact & AI Enhanced Trading Signals - baoquankhu1.vn
Investor Mood: What are Zenas BioPharma Incs growth levers2026 EndofYear Setup & Expert Approved Trade Ideas - baoquankhu1.vn
Bronstein, Gewirtz & Grossman, LLC Encourages Zenas BioPharma, Inc. (ZBIO) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Experienced Healthcare Investor Buys Shares Of Zenas Biopharma – Insider Weekends (NASDAQ:ZBIO) - Seeking Alpha
ZBIO SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
Assessing Zenas BioPharma (ZBIO) Valuation After US$300 Million Equity And Convertible Notes Financing - Sahm
Zenas BioPharma's Key Milestones and Market Context: Holding Through the BLA (NASDAQ:ZBIO) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Is Investigating Zenas BioPharma, Inc. (ZBIO) And Encourages Shareholders to Connect - ACCESS Newswire
Zenas BioPharma Director Makes Bold New Move With Fresh Stock Purchase - TipRanks
Zenas BioPharma Director Increases Stake with $70K Stock Purchase - National Today
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 By Investing.com - Investing.com Canada
Lu Hongbo buys Zenas Biopharma (ZBIO) shares worth $70,197 - Investing.com
Insider Buying: Zenas BioPharma (NASDAQ:ZBIO) Director Buys 3,768 Shares of Stock - marketbeat.com
Leon Moulder boosts Zenas BioPharma (ZBIO) stake to 4.794% ownership - Stock Titan
Zenas BioPharma (ZBIO) director-affiliated funds purchase 3,768 shares - Stock Titan
Zenas BioPharma (NASDAQ:ZBIO) Trading Up 7.6% Following Insider Buying Activity - MarketBeat
Zenas Biopharma Inc (ZBIO) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.14%
0.48%
자본화:
|
볼륨(24시간):